SBH
RIGL icon

Segall Bryant & Hamill’s Rigel Pharmaceuticals RIGL Stock Holding History

Segall Bryant & Hamill’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
45,878
+8,683
+23% +$268K 0.02% 470
2026
Q1 		$1.01M Sell
37,195
-61
-0.2% -$2.05K 0.01% 508
2025
Q4 		$1.6M Buy
37,256
+1,255
+3% +$47.3K 0.02% 466
2025
Q3 		$1.02M Hold
36,001
– – 0.01% 502
2025
Q2 		$674K Hold
36,001
– – 0.01% 528
2025
Q1 		$648K Sell
36,001
-258
-0.7% -$5.23K 0.01% 534
2024
Q4 		$610K Buy
+36,259
New +$695K 0.01% 545

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Segall Bryant & Hamill's RIGL Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Rigel Pharmaceuticals (RIGL) stake by 23% in Q2 2026, buying an estimated $268K and bringing the position to 45,878 shares worth $1.79M. The position accounts for 0.02% of the portfolio, ranked #470.

Segall Bryant & Hamill first reported a position in RIGL in Q4 2024 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Segall Bryant & Hamill held 45,878 shares of Rigel Pharmaceuticals worth $1.79M as of Q2 2026.
  • Segall Bryant & Hamill bought 8,683 Rigel Pharmaceuticals shares in Q2 2026, an estimated $268K.
  • Rigel Pharmaceuticals made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #470 holding.
  • Segall Bryant & Hamill first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.